Inventor
REAPER PHILIP MICHAEL
GB18 patents
⚠️ This page may combine multiple inventors who share the name “REAPER PHILIP MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHARRIER JEAN-DAMIEN
10 patentsUS8841308B2Sep 23, 2014
Pyrazin-2-amines useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN54 citations98
US8962631B2Feb 24, 2015
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN31 citations94
US8410112B2Apr 2, 2013
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN56 citations93
US9096584B2Aug 4, 2015
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN18 citations84
US9062008B2Jun 23, 2015
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN14 citations84
US8969356B2Mar 3, 2015
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN18 citations84
US8623869B2Jan 7, 2014
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN20 citations84
US9334244B2May 10, 2016
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN12 citations83
US8877759B2Nov 4, 2014
Aminopyrazines as ATR kinase inhibitors
CHARRIER JEAN-DAMIEN16 citations83
US9630956B2Apr 25, 2017
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN0 citations39
VERTEX PHARMA
8 patentsUS9701674B2Jul 11, 2017
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA22 citations94
US9365557B2Jun 14, 2016
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA27 citations94
US10961232B2Mar 30, 2021
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA2 citations73
US10479784B2Nov 19, 2019
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA3 citations72
US10813929B2Oct 27, 2020
Treating cancer with ATR inhibitors
VERTEX PHARMA2 citations71
US10478430B2Nov 19, 2019
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
VERTEX PHARMA3 citations69
US11110086B2Sep 7, 2021
Compounds useful as inhibitors of ATR kinase and combination therapies thereof
VERTEX PHARMA1 citations59
US11464774B2Oct 11, 2022
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
VERTEX PHARMA0 citations41